Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Champions Oncology, Inc. (CSBR) vs Pliant Therapeutics, Inc. (PLRX)

Champions Oncology, Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Pliant Therapeutics, Inc. are of similar size ($70.6M and $68.9M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −49.0%. Pliant Therapeutics, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 17 metrics below, Pliant Therapeutics, Inc. leads on 9 and Champions Oncology, Inc. on 8.

Valuation

Metric CSBR PLRX Biotechnology median
P/E n/m n/m 7.88
P/S 1.12 13.30 11.47
P/B 15.27 0.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 226.74 0.64 0.74
EV/Sales 1.16 (12.09) 10.73
Earnings yield (1.63%) (137.96%) (28.84%)
Free cash flow yield (8.98%) (105.61%) (23.03%)

Profitability

Metric CSBR PLRX Biotechnology median
Gross margin 49.82% 0.00% 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (50.29%) (57.72%)
Return on assets (3.56%) (37.69%) (49.22%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR PLRX Biotechnology median
Revenue growth (TTM) 6.65% (48.95%) 5.64%
EPS growth (last fiscal year) (124.24%) 29.97% —
Revenue growth, 5-year CAGR 7.68% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR PLRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 9.90 4.73
Net debt to EBITDA (20.56) 1.27 0.96

Dividend

Metric CSBR PLRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CSBR PLRX Biotechnology median
Market cap 68.90m 70.59m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack